CacyBP/SIP enhances multidrug resistance of pancreatic cancer cells by regulation of P-gp and Bcl-2

Apoptosis

Volumn 18, Issue 7, 2013, Pages 861-869

  Chen, Xiong ^a   Zheng, Peichan ^b   Xue, Zengfu ^c   Li, Jie ^a   Wang, Wenwu ^a   Chen, Xi ^a   Xie, Fangwei ^a   Yu, Zongyang ^a   Ouyang, Xuenong ^a  

^a FUZHOU GENERAL HOSPITAL   (China)

^b FUJIAN MEDICAL UNIVERSITY   (China)

^c THE FIRST AFFILIATED HOSPITAL OF XIAMEN UNIVERSITY   (China)

Author keywords

Apoptosis; CacyBP SIP; Multidrug resistance; Pancreatic cancer

Indexed keywords

BINDING PROTEIN; CALCYCLIN BINDING PROTEIN; CASPASE 3; CASPASE 8; CISPLATIN; DOXORUBICIN; FLUOROURACIL; GEMCITABINE; MITOMYCIN; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN 1; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; SIAH 1 INTERACTING PROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; MOLECULAR MECHANICS; MULTIDRUG RESISTANCE; PANCREAS CANCER; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA INTERFERENCE; UPREGULATION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CALCIUM-BINDING PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; DEOXYCYTIDINE; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; ORGAN SPECIFICITY; P-GLYCOPROTEIN; PANCREATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2; SIGNAL TRANSDUCTION;

EID: 84878694236     PISSN: 13608185     EISSN: 1573675X     Source Type: Journal    
DOI: 10.1007/s10495-013-0831-9     Document Type: Article

References (30)

1. Morrow CS, Cowan KH (1988) Mechanisms and clinical significance of multidrug resistance. Oncology (Williston Park) 2(55-63):66-68
2. Litman T, Druley TE, Stein WD, Bates SE (2001) From MDR to MXR: new understanding of multidrug resistance systems, their properties and clinical significance. Cell Mol Life Sci 58:931-959
3. Lavie Y, Fiucci G, Liscovitch M (2001) Upregulation of caveolin in multidrug resistant cancer cells: functional implications. Adv Drug Deliv Rev 49:317-323
4. Fan D, Zhang X, Chen X, Mou Z, Hu J, Zhou S et al (2005) Bird's-eye view on gastric cancer research of the past 25 years. J Gastroenterol Hepatol 20:360-365
5. Filipek A, Kuznicki J (1998) Molecular cloning and expression of a mouse brain cDNA encoding a novel protein target of calcyclin. J Neurochem 70:1793-1798
6. Filipek A, Wojda U (1996) p30, a novel protein target of mouse calcyclin (S100A6). Biochem J 320(Pt 2):585-587
7. Matsuzawa SI, Reed JC (2001) Siah-1, SIP, and Ebi collaborate in a novel pathway for beta-catenin degradation linked to p53 responses. Mol Cell 7:915-926
8. Schneider G, Nieznanski K, Jozwiak J, Slomnicki LP, Redowicz MJ, Filipek A (2010) Tubulin binding protein, CacyBP/SIP, induces actin polymerization and may link actin and tubulin cytoskeletons. Biochim Biophys Acta 1803:1308-1317
9. Chen X, Han G, Zhai H, Zhang F, Wang J, Li X et al (2008) Expression and clinical significance of CacyBP/SIP in pancreatic cancer. Pancreatology 8:470-477
10. Chen X, Mo P, Li X, Zheng P, Zhao L, Xue Z et al (2011) CacyBP/SIP protein promotes proliferation and G1/S transition of human pancreatic cancer cells. Mol Carcinog 50:804-810
11. Kilanczyk E, Gwozdzinski K, Wilczek E, Filipek A (2012) Up-regulation of CacyBP/SIP during rat breast cancer development. Breast Cancer. doi: 10.1007/s12282-012-0399-1
12. Kilanczyk E, Wasik U, Filipek A (2012) CacyBP/SIP phosphatase activity in neuroblastoma NB2a and colon cancer HCT116 cells. Biochem Cell Biol 90:558-564
13. Ning X, Sun S, Hong L, Liang J, Liu L, Han S et al (2007) Calcyclin-binding protein inhibits proliferation, tumorigenicity, and invasion of gastric cancer. Mol Cancer Res 5:1254-1262
14. Schneider G, Filipek A (2010) S100A6 binding protein and Siah-1 interacting protein (CacyBP/SIP): spotlight on properties and cellular function. Amino Acids 41(4):773-780
15. Zhai H, Shi Y, Jin H, Li Y, Lu Y, Chen X et al (2008) Expression of calcyclin-binding protein/Siah-1 interacting protein in normal and malignant human tissues: an immunohistochemical survey. J Histochem Cytochem 56:765-772
16. Zhao Y, You H, Liu F, An H, Shi Y, Yu Q et al (2002) Differentially expressed gene profiles between multidrug resistant gastric adenocarcinoma cells and their parental cells. Cancer Lett 185:211-218
17. Shi Y, Hu W, Yin F, Sun L, Liu C, Lan M et al (2004) Regulation of drug sensitivity of gastric cancer cells by human calcyclin-binding protein (CacyBP). Gastric Cancer 7:160-166
18. Shi Y, Zhai H, Wang X, Wu H, Ning X, Han Y et al (2002) Multidrug-resistance-associated protein MGr1-Ag is identical to the human 37-kDa laminin receptor precursor. Cell Mol Life Sci 59:1577-1583
19. Guo C, Ding J, Yao L, Sun L, Lin T, Song Y et al (2005) Tumor suppressor gene Runx3 sensitizes gastric cancer cells to chemotherapeutic drugs by downregulating Bcl-2, MDR-1 and MRP-1. Int J Cancer 116:155-160
20. Cheng W, Liu T, Wan X, Gao Y, Wang H (2012) MicroRNA-199a targets CD44 to suppress the tumorigenicity and multidrug resistance of ovarian cancer-initiating cells. FEBS J 279:2047-2059
21. Liu Q, Mittal R, Emami CN, Iversen C, Ford HR, Prasadarao NV (2012) Human isolates of Cronobacter sakazakii bind efficiently to intestinal epithelial cells in vitro to induce monolayer permeability and apoptosis. J Surg Res 176:437-447
22. Sun S, Ning X, Liu J, Liu L, Chen Y, Han S et al (2007) Overexpressed CacyBP/SIP leads to the suppression of growth in renal cell carcinoma. Biochem Biophys Res Commun 356:864-871
23. Schneider G, Filipek A (2011) S100A6 binding protein and Siah-1 interacting protein (CacyBP/SIP): spotlight on properties and cellular function. Amino Acids 41:773-780
24. Wang N, Ma Q, Wang Y, Ma G, Zhai H (2010) CacyBP/SIP expression is involved in the clinical progression of breast cancer. World J Surg 34:2545-2552
25. Agrawal M, Abraham J, Balis FM, Edgerly M, Stein WD, Bates S et al (2003) Increased 99mTc-sestamibi accumulation in normal liver and drug-resistant tumors after the administration of the glycoprotein inhibitor, XR9576. Clin Cancer Res 9:650-656
26. Cabot MC, Giuliano AE, Han TY, Liu YY (1999) SDZ PSC 833, the cyclosporine A analogue and multidrug resistance modulator, activates ceramide synthesis and increases vinblastine sensitivity in drug-sensitive and drug-resistant cancer cells. Cancer Res 59:880-885
27. Zhang D, Fan D (2010) New insights into the mechanisms of gastric cancer multidrug resistance and future perspectives. Future Oncol 6:527-537
28. Hong L, Ning X, Shi Y, Shen H, Zhang Y, Lan M et al (2004) Reversal of multidrug resistance of gastric cancer cells by down-regulation of ZNRD1 with ZNRD1 siRNA. Br J Biomed Sci 61:206-210
29. Nys K, Agostinis P (2012) Bcl-2 family members: essential players in skin cancer. Cancer Lett 320:1-13
30. Hardwick JM, Chen YB, Jonas EA (2012) Multipolar functions of BCL-2 proteins link energetics to apoptosis. Trends Cell Biol 22:318-328